When patients have multiple prescriptions, especially for long term conditions, refill dates often are not aligned and create barriers to adherence. So, pharmacies have been integrating medication synchronization programs into their workflow. Medication synchronization enables patients to fill all their…
Find out how a national retail pharmacy used artificial intelligence (AI) to generate a 2.3 times uplift in medication adherence. At the same time they improved targeting of dual patient interventions to make them more cost-effective. Making dual interventions for…
Are you measuring what matters most for your brand? Many key performance indicators (KPIs) are used to measure the success of adherence programs, and they can vary across different pharmaceutical companies. According to Andrea Kasprzyk, Director of Sales at AllazoHealth,…
We live in exciting times for adherence, and the pharma industry is playing a critical role, according to Mark Degatano, a pharmaceutical industry analytics expert who is on the advisory board of AllazoHealth. Degatano’s expertise comes from 24 years with…
Are you responsible for improving your plan’s quality ratings? Learn how to improve your performance on Star and other quality measures. Download our deck and get specific advice for payers on: The influence of population mix on performance Which patients…
With medication non-adherence costing the industry more than $600 billion a year, many pharmaceutical companies are creating medication adherence programs, often in conjunction with pharmacists and payers. According to Andrea Kasprzyk, Director of Sales at AllazoHealth, "The objective of an…
What do payers consider as they grapple with the medication access and adherence needs of at-risk patients during the Covid-19 pandemic? Experts at McMann Managed Markets and Syneos Health surveyed their proprietary payer advisory boards to find out. Payers respond…
Pharmacies can use artificial intelligence to make adherence improvements that meet the goals of their payer contracts, specifically the ones known as DIR (direct and indirect remuneration). When it comes to getting reimbursements, adherence plays a key role in…
AllazoHealth COO William Grambley explains in this article: "You need to be explicit about AI program constraints upfront. Otherwise you can get to unintended consequences." "Future of Medicine with Artificial Intelligence," Biosupply Trends Quarterly, Fall 2019. Read article here